Early in 2015 St. Jude Medical agreed to pay about $64 million to settle the Riata defibrillator lawsuits, reports AboutLawsuits.com. The company agreed to pay 950 patients $14.25 million and settled for $50 million with shareholders.
Leads from defibrillator implants deliver electric shocks to restore normal heart rhythm, and in 2011, the Food and Drug Administration reported that the insulation on the leads should last 10 years, explains the Star Tribune. However, a defect in the insulation made some leads deteriorate within four years. St. Jude Medical took Riata leads off the market in 2010 but did not disclose until 2011 that it knew about reports of two deaths and one serious injury due to the defective leads.